EFSA approves use of “Chromium Picolinate” in foods

New York-based Nutrition 21 Inc; the developer and marketer of ingredients for dietary supplements, foods and beverages, and animal nutrition, has announced the European Food Safety Authority (EFSA) issued its safety assessment supporting the use of chromium picolinate in foods intended for the general population in the European Union (EU).

In its safety assessment, EFSA concluded that “chromium picolinate” has a large margin of safety supporting its use as a source of chromium up to the maximum level established by the World Health Organization (WHO).

Chromium picolinate is the chemical compound that is sold as a nutritional supplement to prevent or treat chromium deficiency.

There are claims that the picolinate form of chromium supplementation aids in reducing insulin resistance, particularly in diabetics, but a meta-analysis of chromium supplementation studies showed no association between chromium and glucose or insulin concentrations for non-diabetics, and inconclusive results for diabetics.

EFSA’s safety review was in response to Nutrition 21’s application to market “Chromax chromium picolinate” as a source of chromium in conventional foods in Europe. The safety assessment is an initial step in obtaining formal EU approval of chromium picolinate as an acceptable form of chromium for use in foods. The company expects the formal approval will be issued in 2011.

“The safety review was extensive and included a review of Nutrition 21’s safety data on Chromax chromium picolinate, our manufacturing and product specifications, and the long-term, high-dose, toxicity studies independently conducted by the U.S. National Toxicology Program,” said James Komorowski, vice president – R&D at Nutrition 21.

source: http://www.fnbnews.com/article/detnews.asp?articleid=28891&sectionid=23